Abstract Background Comprehensive genomic profiling (CGP) testing has been covered by public health insurance and its clinical application started in Japan since June 2019. All the results of CGP are sent to Center for Cancer Genomics Advanced Therapeutics (C-CAT) shared with clinicians after discussion at Expert Panel (EP). Here we report analysis adult central nervous system (CNS) tumors regi...